Looking Beyond Profit to Harness Technology and Influence for Purpose in Healthcare

In the constantly changing landscape of technology and innovation, leveraging one’s resources for a purpose in healthcare beyond profit is becoming increasingly vital. Particularly in sectors like healthcare, the responsibility to contribute doesn’t merely revolve around monetary gains but is deeply rooted in purpose and influence. Harnessing the power of technology, intellectual property, and human capital to make a positive impact is the new directive for leaders today.

As Brian Urban, the Director of Innovation and Emerging Markets for FinThrive aptly puts it, purpose in healthcare is not just about waiting for opportunities, but proactively seeking ways to share your voice and make a difference. Tune into Highway to Health for more of his insights.

Recent Episodes

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…